Cargando…
Cost-effectiveness analysis of percutaneous coronary intervention for single-vessel coronary artery disease: an economic evaluation of the ORBITA trial
OBJECTIVE: To evaluate the cost-effectiveness of percutaneous coronary intervention (PCI) compared with placebo in patients with single-vessel coronary artery disease and angina despite anti-anginal therapy. DESIGN: A cost-effectiveness analysis comparing PCI with placebo. A Markov model was used to...
Autores principales: | McCreanor, Victoria, Nowbar, Alexandra, Rajkumar, Christopher, Barnett, Adrian G, Francis, Darrel, Graves, Nicholas, Boden, William E, Weintraub, William S, Al-Lamee, Rasha, Parsonage, William A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875263/ https://www.ncbi.nlm.nih.gov/pubmed/33563623 http://dx.doi.org/10.1136/bmjopen-2020-044054 |
Ejemplares similares
-
Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: a substudy of the ORBITA trial( )
por: Ganesananthan, Sashiananthan, et al.
Publicado: (2022) -
Remote digital smart device follow-up in prospective clinical trials: early insights from ORBITA-2, ORBITA-COSMIC, and ORBITA-STAR
por: Ganesananthan, Sashiananthan, et al.
Publicado: (2022) -
The Placebo-Controlled Effect of Percutaneous Coronary Intervention on Exercise Induced Changes in Anti-Malondialdehyde-LDL Antibody Levels in Stable Coronary Artery Disease: A Substudy of the ORBITA Trial
por: Hartley, Adam, et al.
Publicado: (2021) -
Quality of Life Assessment in Trials of Revascularization for Chronic Stable Angina: Insights from ORBITA and the Implications of Blinding
por: Nowbar, Alexandra N, et al.
Publicado: (2021) -
A systematic review and critical analysis of cost-effectiveness studies for coronary artery disease treatment
por: McCreanor, Victoria, et al.
Publicado: (2018)